Get the Stockscreener App
3.33
4.58%
-0.16
After Hours:
3.36
0.03
+0.90%
Bioline Rx Ltd Adr Stock (BLRX) Forecast
The Bioline Rx Ltd Adr (BLRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.0554, representing a -38.28% decrease from the current price of $3.33. The highest analyst price target is $2.0338, and the lowest is $2.0769.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BLRX Price Target
Average 1.9102
(-42.64% Downside)
Is Bioline Rx Ltd Adr (BLRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 83.29 | Sell |
| STOCH(9,6) | 77.88 | Neutral |
| STOCHRSI(14) | 79.59 | Neutral |
| MACD(12,26) | 0.8903 | Buy |
| ADX(14) | 50.04 | Buy |
| William %R | -25.55 | Neutral |
| CCI(14) | 83.48 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.477
Buy
|
2.6498
Buy
|
| MA20 |
1.2971
Buy
|
1.8253
Buy
|
| MA50 |
0.6588
Buy
|
1.0235
Buy
|
| MA100 |
0.5746
Buy
|
0.7595
Buy
|
| MA200 |
0.6256
Buy
|
0.7774
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, BLRX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on BLRX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 83.29 indicates that BLRX is overbought. This suggests that BLRX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 77.88 indicates that BLRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 79.59 indicates that BLRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 50.04 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 83.48 indicates that BLRX is still overbought but not to an extreme extent.
Long-term BLRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bioline Rx Ltd Adr financial reports and earnings history, Bioline Rx Ltd Adr (BLRX) stock could reach $4.2511 by 2030, $3.5567 by 2040 and $10.75 by 2050. See the projected annual prices until 2050 of the Bioline Rx Ltd Adr stock below:
- Bioline Rx Ltd Adr (BLRX) is expected to reach an average price of $0.4943 in 2035, with a high prediction of $0.5393 and a low estimate of $0.4943. This indicates an $-85.16% rise from the last recorded price of $3.33.
- Bioline Rx Ltd Adr (BLRX) stock is projected to chart a bullish course in 2040, with an average price target of $3.3724, representing an $1.27% surge from its current level. The forecast ranges from a conservative $3.4224 to a sky-high $3.5567.
- Our analysts predict Bioline Rx Ltd Adr (BLRX) to jump 107.78% by 2045, soaring from $6.5726 to an average price of $6.9189, potentially reaching $6.9266. While $6.5726 is the low estimate, the potential upside is significant.
- Bioline Rx Ltd Adr (BLRX) stock is expected to climb by 2050, reaching an average of $10.62, a $218.81% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.75 and $10.74, respectively, highlighting the market's uncertainty.
Bioline Rx Ltd Adr Stock (BLRX) Year by Year Forecast
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2025
Bioline Rx Ltd Adr Stock (BLRX) is expected to reach an average price of $2.2289 in 2025, with a high prediction of $2.7563 and a low estimate of $1.7014. This indicates an -33.07% fall from the last recorded price of $3.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $2.2254 | $2.0769 | $2.0338 | -33.17% |
| April, 2025 | $2.7755 | $2.3795 | $2.7563 | -16.65% |
| May, 2025 | $2.3845 | $2.4045 | $2.7276 | -28.39% |
| June, 2025 | $2.337 | $2.3714 | $2.3157 | -29.82% |
| July, 2025 | $2.1051 | $2.2109 | $2.1639 | -36.78% |
| August, 2025 | $2.0277 | $2.1577 | $2.102 | -39.11% |
| September, 2025 | $1.6102 | $1.7645 | $1.8433 | -51.65% |
| October, 2025 | $2.0383 | $1.7014 | $1.8383 | -38.79% |
| November, 2025 | $2.0108 | $2.0496 | $1.9658 | -39.61% |
| December, 2025 | $1.599 | $2.0377 | $2.0021 | -51.98% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2026
The predicted value for Bioline Rx Ltd Adr (BLRX) in 2026 is set at an average of $1.594. Estimates vary from a peak of $3.1778 to a trough of $0.0102, indicating an -52.13% surge from the present price of $3.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.2015 | $1.3515 | $1.0065 | -63.92% |
| February, 2026 | $0.864 | $1.064 | $1.1972 | -74.05% |
| March, 2026 | $0.6265 | $0.7265 | $0.8355 | -81.19% |
| April, 2026 | $0.00467 | $0.151 | $0.881 | -99.86% |
| May, 2026 | $0.2172 | $0.3249 | $0.4197 | -93.48% |
| June, 2026 | $0.3497 | $0.4341 | $0.3484 | -89.50% |
| July, 2026 | $0.2978 | $0.0522 | $3.1778 | -91.06% |
| August, 2026 | $0.3004 | $0.2991 | $0.1904 | -90.98% |
| September, 2026 | $0.1815 | $0.0985 | $0.6005 | -94.55% |
| October, 2026 | $0.189 | $0.0102 | $0.4309 | -94.32% |
| November, 2026 | $0.0335 | $0.0334 | $0.2034 | -98.99% |
| December, 2026 | $0.0817 | $0.1092 | $0.1208 | -97.55% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bioline Rx Ltd Adr (BLRX) is $0.5327, with a high forecast of $1.0399 and a low forecast of $0.0255. This indicates an -84.00% decrease from the last price of $3.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1158 | $0.0758 | $0.3613 | -96.52% |
| February, 2027 | $0.0567 | $0.0255 | $0.2433 | -98.30% |
| March, 2027 | $0.3349 | $0.1523 | $0.3608 | -89.94% |
| April, 2027 | $0.5774 | $0.4805 | $0.5175 | -82.66% |
| May, 2027 | $0.7699 | $0.7929 | $0.6786 | -76.88% |
| June, 2027 | $0.908 | $0.8155 | $0.8624 | -72.73% |
| July, 2027 | $0.6905 | $0.7505 | $0.8437 | -79.26% |
| August, 2027 | $0.9131 | $0.6962 | $0.8031 | -72.58% |
| September, 2027 | $0.6912 | $1.1043 | $1.0399 | -79.24% |
| October, 2027 | $0.9137 | $0.7925 | $0.8337 | -72.56% |
| November, 2027 | $0.6862 | $0.8993 | $0.8506 | -79.39% |
| December, 2027 | $0.2144 | $0.4644 | $0.7531 | -93.56% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2028
In 2028, Bioline Rx Ltd Adr (BLRX) is projected to reach an average price of $0.5936, with a high projection of $1.1538 and a low estimate of $0.0333. This indicates an -82.18% fall from the last price of $3.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5269 | $0.42 | $0.4769 | -84.18% |
| February, 2028 | $1.0444 | $0.5225 | $1.0184 | -68.64% |
| March, 2028 | $1.0504 | $1.0676 | $1.0519 | -68.46% |
| April, 2028 | $1.1479 | $1.0568 | $1.1301 | -65.53% |
| May, 2028 | $1.1882 | $1.135 | $1.1187 | -64.32% |
| June, 2028 | $1.0327 | $1.0407 | $1.1538 | -68.99% |
| July, 2028 | $1.0542 | $1.0676 | $1.0468 | -68.34% |
| August, 2028 | $1.0123 | $1.0314 | $1.0189 | -69.60% |
| September, 2028 | $0.5264 | $0.642 | $0.9521 | -84.19% |
| October, 2028 | $0.2764 | $0.4064 | $0.3152 | -91.70% |
| November, 2028 | $0.2654 | $0.0333 | $0.2854 | -92.03% |
| December, 2028 | $0.2579 | $0.1699 | $0.4541 | -92.25% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2029
The 2029 price forecast for Bioline Rx Ltd Adr Stock (BLRX) is $1.5107 on average, with a high prediction of $3.0148 and a low estimate of $0.00664. This represents an -54.63% decrease from the previous price of $3.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2748 | $0.0196 | $0.4517 | -91.75% |
| February, 2029 | $0.0323 | $0.00774 | $0.3691 | -99.03% |
| March, 2029 | $0.7997 | $0.00664 | $1.3654 | -75.98% |
| April, 2029 | $0.5072 | $0.2472 | $1.1641 | -84.77% |
| May, 2029 | $0.4091 | $0.186 | $0.6291 | -87.72% |
| June, 2029 | $0.5566 | $0.3735 | $0.9235 | -83.29% |
| July, 2029 | $0.6641 | $0.5509 | $0.9409 | -80.06% |
| August, 2029 | $0.3559 | $0.2015 | $0.7028 | -89.31% |
| September, 2029 | $0.4034 | $0.2047 | $0.489 | -87.89% |
| October, 2029 | $0.6753 | $0.3865 | $0.6965 | -79.72% |
| November, 2029 | $0.00924 | $0.0116 | $0.6596 | -99.72% |
| December, 2029 | $4.1428 | $0.0176 | $3.0148 | +24.41% |
Bioline Rx Ltd Adr Stock (BLRX) Price Forecast for 2030
Bioline Rx Ltd Adr Stock (BLRX) is expected to reach an average price of $5.4811 in 2030, with a high forecast of $6.8527 and a low forecast of $4.1096. This signifies an +64.60% surge from the last price of $3.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.2856 | $4.2936 | $4.2511 | +28.70% |
| February, 2030 | $4.8111 | $4.1096 | $4.2711 | +44.48% |
| March, 2030 | $5.4011 | $5.4261 | $5.1988 | +62.20% |
| April, 2030 | $6.2712 | $6.2198 | $6.0012 | +88.32% |
| May, 2030 | $6.3974 | $6.37 | $6.3875 | +92.11% |
| June, 2030 | $6.1725 | $6.2125 | $6.0725 | +85.36% |
| July, 2030 | $6.0888 | $6.1688 | $6.1338 | +82.85% |
| August, 2030 | $6.6752 | $6.1308 | $6.2338 | +100.46% |
| September, 2030 | $6.1098 | $6.1688 | $6.1551 | +83.48% |
| October, 2030 | $6.2951 | $6.0514 | $6.1251 | +89.04% |
| November, 2030 | $6.8702 | $6.3364 | $6.3402 | +106.31% |
| December, 2030 | $6.8752 | $6.9239 | $6.8527 | +106.46% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):